Siemens Healthineers announced it has secured FDA clearance for its Magnetom Vida 3 Tesla magnetic resonance imaging system. The company...
St. Jude Medical, Inc. announced FDA approval for full-body magnetic resonance (MR) Conditional labeling for the Proclaim Elite Spinal Cord...
St. Jude Medical, Inc. has announced CE mark approval for full-body magnetic resonance (MR) conditional labeling conditional labeling of the...
Urologists face a dilemma when a lesion identified on multiparametric magnetic resonance imaging is benign on image guided fusion biopsy.
St.Jude Medical has announced CE Mark approval for magnetic resonance (MR) conditional labeling for the company�s Quadra Allure MP cardiac...
Philips has received FDA clearance for the Ingenuity TF PET/MR, a whole body positron emission tomography/magnetic resonance (PET/MR) imaging system....
Aims: To assess the ability of cardiovascular magnetic resonance (CMR) to (i) measure changes in response to chemotherapy; (ii) assess the correlation between haematological response and changes in extracellular volume (ECV); and (iii) assess the association between changes in ECV and prognosis over and above existing predictors.
Boston Scientific has received FDA approval for the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance...
Pompe disease is a rare neuromuscular disorder caused by a deficiency of a lysosomal enzyme, acid α-glucosidase. Macroglossia is a classic clinical sign of several inherited myopathies and has also been reported to occur progressively in late-onset Pompe disease (LOPD).
Medtronic plc is the first company to receive FDA approval for its suite of cardiac rhythm and heart failure devices...